Google TrendSOCIAL SECURITY 2027 COLA ANNOUNCEMENT (500+) — When will 2027’s Social Security COLA be announced?
The 24/7 Global Portal

World News, Markets & Google Trends

Aggregated real-time headlines, trending Google search queries, and verified dispatches in one single page.

Category:All HeadlinesWorld & GeopoliticsMarkets & EconomyTech & AIPoliticsSearch results for: "Clostridioides difficile" (30 stories)

Top Headline Story

Natural compound shows promise against C. difficile while largely sparing healthy gut bacteria
Lead StoryMedical Xpresstech
2d ago

Natural compound shows promise against C. difficile while largely sparing healthy gut bacteria

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPdTg5d2Y3ZmZmNmZwZHdQc3AxYWtuOXRHWDBOdHdDUDhFOVJ6Y0daUm85WTVNN3M1U0F5SHliZmVIMHdvbE1tNlZNMXF1YlNlR05XbHBmMzR4elh6X25CVFJ6YXhPUms3M3dFTDNWaVhIODZDQWNzOUJ5d0FoQUdlX3Q5blZUM21JNjR5QkJ0OA?oc=5" target="_blank">Natural compound shows promise against C. difficile while largely sparing healthy gut bacteria</a>  <font color="#6f6f6f">Medical Xpress</font>

Real-time search volume
500+19m ago

social security 2027 cola announcement

When will 2027’s Social Security COLA be announced?

200+29m ago

benfica vs vitória sc

Benfica tem 'roupa nova' para receber o V. Guimarães: o onze provável

200+29m ago

energy ceasefire

Trump announces partial ceasefire in Ukraine war as Zelenskyy says deal is ‘news to me’

200+29m ago

elliot anderson

James McAtee: How Oliver Glasner has transformed Nottingham Forest midfielder from forgotten man to his new Adam Wharton

Search Results for "Clostridioides difficile"

Updated every 3 minutes via FreeNewsApi, GNews, Currents API & Google News

29 stories displayed
Dual Toxin and Glutamate Dehydrogenase (GDH) Enzyme Immuno Assay (EIA) Tests Market Forecast Points Higher Toward 2035, Driven by Rising C. Difficile Incidence
IndexBoxmarkets

Dual Toxin and Glutamate Dehydrogenase (GDH) Enzyme Immuno Assay (EIA) Tests Market Forecast Points Higher Toward 2035, Driven by Rising C. Difficile Incidence

<a href="https://news.google.com/rss/articles/CBMikAJBVV95cUxPTGVLTTVMSG1yc21YdFhWVFJndlJoM0tTQWdvVlhHelhCc0pINVhKbVBKYXo1cl9pc3BicjdTWDZLQ01sUEZ4a1lKejh6NmF1RmFxS1VSb252Mi1VOVVnaWc1azlNNnlrakI3WlZ2Y01meGxBZ29vM0NDMG1oR25WbmY0WEdrXzZic0xLcTJYMlRSR2FrM0RGazhwcGREdk8tNGdtdk5hMHNTRTV1ZUg5Ul9EV1lhY2RWODZRZWctWTlRSXhPS0twMC1MQ05KRGgwNDlpSWdaZm5fOVFOVDFvODZBb29WZjFqR2FJdDlCM1JyMU0xLV96UEFYMjlLZ1U3RUJFX0lDYnM4ZjRjRjV6Rw?oc=5" target="_blank">Dual Toxin and Glutamate Dehydrogenase (GDH) Enzyme Immuno Assay (EIA) Tests Market Forecast Points Higher Toward 2035, Driven by Rising C. Difficile Incidence</a>  <font color="#6f6f6f">IndexBox</font>

Experimental human colonisation with non-toxigenic Clostridioides difficile : a placebo-controlled randomised clinical trial
Naturegeneral

Experimental human colonisation with non-toxigenic Clostridioides difficile : a placebo-controlled randomised clinical trial

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE9WWllGZ3ZXYTNtQ0hGSzBJQkVGMlc3UzhZVUhiOUN0aFRXekdLaWFia0gyeFBGOTN5aWdZaHRxOEJ1WUkwb2ZxYkt0Rk1jc0IyYlRjRlNOSEdjV2JfcGIw?oc=5" target="_blank">Experimental human colonisation with non-toxigenic Clostridioides difficile : a placebo-controlled randomised clinical trial</a>  <font color="#6f6f6f">Nature</font>

How C. diff spreads in a hospital oncology ward
healthcare-in-europe.comgeneral

How C. diff spreads in a hospital oncology ward

<a href="https://news.google.com/rss/articles/CBMiogFBVV95cUxNQmJtM3VQWGJFbFh0bDVEc0pBVnJjSVN4NS1nSTlERC1VZUpXNEtPaGZGbHZwc0Y4Tm5fd0x5RnV1eGptS1ozRmU2dUx6ZmN5QXhOaXhQSkNTU0V5WG1tYzJwODlKYkxKcmQ4RkhCT1lieGRIcTF0V0ZuOUltV2VWOG5FWWRCdlZ5VUYxTWlKRjRqblVHb1RpdDZleE1IWUhPTVE?oc=5" target="_blank">How C. diff spreads in a hospital oncology ward</a>  <font color="#6f6f6f">healthcare-in-europe.com</font>

Bacterial infection may alter developing gut
National Institutes of Health (NIH) | (.gov)general

Bacterial infection may alter developing gut

<a href="https://news.google.com/rss/articles/CBMingFBVV95cUxNbEhoa1BlSS1NT2Z3SlEyeHJNbmg2UHJMNklIUkNObnV6dmdUVWplRGgzbGpGcTdnaTRpSm9fMGxHWXlSZm1NakR3dTFFSU9IZWFfd2tEMFhzbXRWUlloUzdaZ1RsSDVtaGxBZEhQak9VQTVjNnNlV19QZUpHaEZQbk1Rcjk0ekR3R0hHOVhYc2RiQk9GUEtaR1R2d0s0Zw?oc=5" target="_blank">Bacterial infection may alter developing gut</a>  <font color="#6f6f6f">National Institutes of Health (NIH) | (.gov)</font>

Complete genome sequence of Clostridioides difficile NCTC 12727, a PCR ribotype 001 reference strain
ASM Journalstech

Complete genome sequence of Clostridioides difficile NCTC 12727, a PCR ribotype 001 reference strain

<a href="https://news.google.com/rss/articles/CBMiXkFVX3lxTE5MUEpxRlRPM21PNGJZX2xaQkxPRWhrREVlX1FUa3U2VGdDV3g0LW5QVUlyOE1TSWRBT2VVOGNYSUpsdXNhUVBhWmRLZk94cUdJVy1pMHBaaTBIb1hzdEE?oc=5" target="_blank">Complete genome sequence of Clostridioides difficile NCTC 12727, a PCR ribotype 001 reference strain</a>  <font color="#6f6f6f">ASM Journals</font>

Case Report: Immune-related colitis complicated by Clostridioides difficile -associated colitis
Frontiersworld

Case Report: Immune-related colitis complicated by Clostridioides difficile -associated colitis

<a href="https://news.google.com/rss/articles/CBMikgFBVV95cUxNVXNCYU1kbHN4cU03a0lGT3ZZNjBCOWZUcXN1MGFtMFJvTTN2VkZvVnN4VkZ3b1JhUEJCd2p3RVZLUTd3ZDBIeV9tXzEzNDR1U2VyemhqdU13T1Q2a2Z4ZWlVMGZUeTRQeGlJM25MdHh1UkhQWTVaR0dpaDk4T0YxUVBSOE1GY2lSM21ZaGt4Y0ZRQQ?oc=5" target="_blank">Case Report: Immune-related colitis complicated by Clostridioides difficile -associated colitis</a>  <font color="#6f6f6f">Frontiers</font>

Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older
Vanderbilt Health Newsscience

Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxQZm5BVjZMc1N0SEYyMTAyZmstbzNWYlkyTXhpQjFHREx4UVZXTVZ6bzEwSC1aWjJkeHVjdk8tcTRTVDB6R0d3ZU1wcGtfMFVCSFJrUEotZkdhSjdTekN3TUlxdzRMVDBzOEFtTGhXUWpqTWY0U281dGp0blZfMG5PRXFRdnZ5eXROWjhfUGhtV0N4Q3dPRzNrUkhTc3lCbm93YnBuXzJBdw?oc=5" target="_blank">Vanderbilt Health evaluating vaccine for C. difficile for people 65 and older</a>  <font color="#6f6f6f">Vanderbilt Health News</font>

Managing Clostridioides difficile in IBD: New Guidance From the American Gastroenterological Association
Medscapegeneral

Managing Clostridioides difficile in IBD: New Guidance From the American Gastroenterological Association

<a href="https://news.google.com/rss/articles/CBMirgFBVV95cUxQNmdEbEo1aU0zWFNQdmMtdkxReC1FenYtYjdMTFhzdVhRNlJvc19OdzdaMEo0VU1XNDgtVFRCR2UyeVFVSl9zYWJrc0ZMa3VJU3gyRkpmUUxBZXVYN0Y4OUxPdEhiVmxlYUV5Vi14OXdZYTZlUzlZWTctTk5xNFBhajZOQnFHVTN6Y2hPOE1vQTJHWHpvUXZUYnBLWHlLX3pVNFU0Q2cwU1R6YU5uZWc?oc=5" target="_blank">Managing Clostridioides difficile in IBD: New Guidance From the American Gastroenterological Association</a>  <font color="#6f6f6f">Medscape</font>

‘I really started to doubt myself’: Young woman’s decade-long struggle with C diff might serve to help others
CIDRAPworld

‘I really started to doubt myself’: Young woman’s decade-long struggle with C diff might serve to help others

<a href="https://news.google.com/rss/articles/CBMixAFBVV95cUxOOXhxSGdaa1NmT1pKbUVwQjhWei1NdmNqUkZfNHRBQjNVaG5CUk1DQ1RNZ0RUTVpqV3V5TW5sSU1aN2FVeDRQcjhUUVphNG00ZUhEUjIyLVdLQmt6Y1ZKZHJXT1l4TV92TkExQmhoRVotQkxRZVVfSk8wdnZQV2t6UzBMYWg3U2ZQaV9NLWFGTWNIdkZYaWZQMHRVQlBRVzNIS0dYeGdyODVYX0pWM3JIN3huLV9uWEozcGdGTHRaU2dlOE5v?oc=5" target="_blank">‘I really started to doubt myself’: Young woman’s decade-long struggle with C diff might serve to help others</a>  <font color="#6f6f6f">CIDRAP</font>

Structure of core assembly of the Clostridioides difficile germinosome
Naturegeneral

Structure of core assembly of the Clostridioides difficile germinosome

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1tVmhnUVpiakpxMG81RXF4Sy03TnNpekJCMlpCVllBTkoyd2lHRjUzVU1JV3llS1RmVC03Y25FNWJISzkwQXlXNkJObE0wRWZRWnZPc0lDY1lRUkw5OUhN?oc=5" target="_blank">Structure of core assembly of the Clostridioides difficile germinosome</a>  <font color="#6f6f6f">Nature</font>

Pharmacological reduction of neutrophil infiltration reduces Clostridioides difficile infection severity
ASM Journalsgeneral

Pharmacological reduction of neutrophil infiltration reduces Clostridioides difficile infection severity

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1pOVZwUTUyRmxsMlFxZlhoanRxd09nbHFRbmFuWlA2NlJWS3Q0UjVTWnA4bGtxeW9QcUxLN0c3REdKdjBVMWF3cGU5LVBEYXBKTjczemdYZHBnRWZKbDNV?oc=5" target="_blank">Pharmacological reduction of neutrophil infiltration reduces Clostridioides difficile infection severity</a>  <font color="#6f6f6f">ASM Journals</font>

Impact of enteral feeding strategies on nosocomial Clostridioides difficile infection-induced diarrhea
Frontiersgeneral

Impact of enteral feeding strategies on nosocomial Clostridioides difficile infection-induced diarrhea

<a href="https://news.google.com/rss/articles/CBMijwFBVV95cUxPMTMzQlowakF3ZWlLWkdTbDBMdFVQQVMxV3VENHpqNGxtbXhQV3ZLa1pyZV9ucUhzRjNtV1pPOHdsQlFaclctdmpCamVSTjlidG8xalBILVRIMGU0NUd6aXZrZjl3UlVBSnpWNHM0OWVVWUVwbXllSkNZWGt5T0YzRnhQWjNia0hJOEtBcXNNdw?oc=5" target="_blank">Impact of enteral feeding strategies on nosocomial Clostridioides difficile infection-induced diarrhea</a>  <font color="#6f6f6f">Frontiers</font>

Sepsis associated with Clostridioides difficile infection carries similar mortality to sepsis of other origin: a propensity score-matched analysis | Scientific Reports
Naturegeneral

Sepsis associated with Clostridioides difficile infection carries similar mortality to sepsis of other origin: a propensity score-matched analysis | Scientific Reports

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE5KZEFwUXpNdW5hZEVWUmI3VndDU3hfblZidXM0bEUzNEdNUlNYTDVDaEdDbFR3MVJhbEludmcwc1JsLVZHU1JUY3FVaWk1WUZKZGFIRTNmMHVEQ3NqWG1r?oc=5" target="_blank">Sepsis associated with Clostridioides difficile infection carries similar mortality to sepsis of other origin: a propensity score-matched analysis | Scientific Reports</a>  <font color="#6f6f6f">Nature</font>

Mechanisms by which proline reductase of Clostridioides difficile promotes efficient metabolism and disease progression in vivo | mBio
ASM Journalsgeneral

Mechanisms by which proline reductase of Clostridioides difficile promotes efficient metabolism and disease progression in vivo | mBio

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE90dHlUMFhOWEgzREk4dXkxRTVhS2xQMENNcDBNQ0JReWhCZkVhcTlPZGtlQll4bXpUU1VfLTVLN29sTzIxSEh2YVNsNDU5WlVUV0hGd3Q5TzNELVJoRnM1YW1qVmQ?oc=5" target="_blank">Mechanisms by which proline reductase of Clostridioides difficile promotes efficient metabolism and disease progression in vivo | mBio</a>  <font color="#6f6f6f">ASM Journals</font>

A single amino acid substitution determines susceptibility of Clostridioides difficile toxin B variants to monoclonal antibody neutralization
Frontiersgeneral

A single amino acid substitution determines susceptibility of Clostridioides difficile toxin B variants to monoclonal antibody neutralization

<a href="https://news.google.com/rss/articles/CBMiswFBVV95cUxOTEYzaF9BdDRFU1ZYX19uQ09FRG5iV2o0LTNVTWZETm9aMzBqaHhRcXhKbU1lOGl1NUQ1WVpOblhSN3ZCVFlIa21kUDl2Zk13RnFuOUxtYTZjSklFeGE3YzBPbWJpNTY5Y1pUSFQydnhGTEMxOWhjV1dGenh5N1dFV3dfdjZQd25hMFM3MGZiY2FTVFFvYjJYbE9KeXNXaTlyZ200djBsZXpydTBTeGt3ODl2OA?oc=5" target="_blank">A single amino acid substitution determines susceptibility of Clostridioides difficile toxin B variants to monoclonal antibody neutralization</a>  <font color="#6f6f6f">Frontiers</font>

Mucosal vaccination clears Clostridioides difficile colonization
Naturegeneral

Mucosal vaccination clears Clostridioides difficile colonization

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBGTjNsOHByVUlDQmlSX0taeV8xem95RjhRTHptbEtsbHdnaWFSOVIyRHB2UlA5U2xyNzRrSjJzVm1xZF9Sc1JNUENLX0s1cGh6eXBmZGtxS2pYeVVKYVEw?oc=5" target="_blank">Mucosal vaccination clears Clostridioides difficile colonization</a>  <font color="#6f6f6f">Nature</font>

Modeling Clostridioides difficile toxin pathogenesis and antiserum protection in an immunocompetent intestine-on-chip platform
Naturetech

Modeling Clostridioides difficile toxin pathogenesis and antiserum protection in an immunocompetent intestine-on-chip platform

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE16ZDN4Nlk5bDY0STUydWh6SzZiY1RtbHJualhyYlQ0QXFTRWpiY1Y1dU5BSnk0VmRsQ1Z2dTZhWjUzZ1dIMzdtRlZ1ZS1xc2xLTVJ3enVvdm9UTkt3b2g4?oc=5" target="_blank">Modeling Clostridioides difficile toxin pathogenesis and antiserum protection in an immunocompetent intestine-on-chip platform</a>  <font color="#6f6f6f">Nature</font>

Pooled analyses of Clostridioides difficile vaccine trials identify baseline predictors for vaccine response
Naturegeneral

Pooled analyses of Clostridioides difficile vaccine trials identify baseline predictors for vaccine response

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTFBGN2VrSUhweU4xX01aUFNBZnFvd280aWN2WDdjckxEbk5xVGR6MDJaa3BQaUJ1YXFTRGRwUEp4b0Vmb052Y19OMlRRU3FQLW9Tc0psSzdOLUFzTHlJSkZn?oc=5" target="_blank">Pooled analyses of Clostridioides difficile vaccine trials identify baseline predictors for vaccine response</a>  <font color="#6f6f6f">Nature</font>

In situ visualization of Clostridioides difficile phenotypic heterogeneity and single-cell morphology during gut infection
Naturegeneral

In situ visualization of Clostridioides difficile phenotypic heterogeneity and single-cell morphology during gut infection

<a href="https://news.google.com/rss/articles/CBMiX0FVX3lxTE1WSDNtb285S05xZkdERWFpbU45UjZuQWZxOFZXdkFRT18tMmFMbnNlUUFxckNJWnZYbG0xSnFScVR3SmZoTlF6bmdGZWc1WEVnWlZTVE5wNDRQNDZzLXo4?oc=5" target="_blank">In situ visualization of Clostridioides difficile phenotypic heterogeneity and single-cell morphology during gut infection</a>  <font color="#6f6f6f">Nature</font>

Reducing Recurrence in C Difficile Infection
Pharmacy Timesgeneral

Reducing Recurrence in C Difficile Infection

<a href="https://news.google.com/rss/articles/CBMilwFBVV95cUxQV1hoYlVYRWhCWG01SE5lNDY4dndoeG9HTlJVREhHbGdzMzQ1Z1dtaFV2SGUxTUR1dWdjaXU4OXpsdktncGd1LUIyMU45YjFJRU1mdjJUWVdLNWtKaHdPQXAzVHdicF91SFBSUklCcnNGVmVqQ2o4Q0Y2RkRxSlVsNjNnSE5wWXRMUm91R19Fdk54WHNodjNN?oc=5" target="_blank">Reducing Recurrence in C Difficile Infection</a>  <font color="#6f6f6f">Pharmacy Times</font>

Whole-genome characteristics of isolates from recurrent Clostridioides difficile infections
ASM Journalsgeneral

Whole-genome characteristics of isolates from recurrent Clostridioides difficile infections

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE8yVG9yZDZaQVE5ZE5VRGhZM05kYWJ2OWdFdDZ5NlZyaDZFc1g2cUVJck5zTVZ5NHdSVmN1TFJ1SVgyN2VuQmVrcmlidFR1Y1oxTWVEdFE0YmJpTmtqOTFqMVRTWjY?oc=5" target="_blank">Whole-genome characteristics of isolates from recurrent Clostridioides difficile infections</a>  <font color="#6f6f6f">ASM Journals</font>

Clostridioides difficile Revisited: What Clinicians Need to Know
European Medical Journalgeneral

Clostridioides difficile Revisited: What Clinicians Need to Know

<a href="https://news.google.com/rss/articles/CBMijgJBVV95cUxOaVJMTmZ0bjIwN1dpVWxHVnJPU3UtMVRZeXp5UFhyT2dCZ0lIUVo4NVNORFBvbmtKUUtqTFFUQkx0Wmx2emtfY3dPUG5Hd09EWkphaVBWQmh6MDJCaV9jeE5tT19uaFNJa0RWdlNPWnU3ZHNOZEhDeUk4S3pySHlyUU9UaWxPMWxMTUdDTW43UjRyMmNZdDNHVDlyeExmazdqQms1UEtuZUZuY2xHQU44aV9iSEctU1NpbHIzRm5kVkhZZDVIbXZqQi01YlBQd2xWVjFuV3NqQ0FiekJ2alZxUFJYR0xVTTJiZndma1N6ZlZHR1FiV0Uwa2dGUGh6RGRZSXJmellwR2huUlZURFE?oc=5" target="_blank">Clostridioides difficile Revisited: What Clinicians Need to Know</a>  <font color="#6f6f6f">European Medical Journal</font>

Impact of Gastric Acid Suppression on Clostridioides difficile Infection: A Systematic Review
Cureusgeneral

Impact of Gastric Acid Suppression on Clostridioides difficile Infection: A Systematic Review

<a href="https://news.google.com/rss/articles/CBMiywFBVV95cUxPWWhXZUJhdm54bEJhZmkwbldBR3ZqWUZTOWRFc19IZ1dweVpET0ZYaXJneE1uMXdtQVdOcUhpcXVPMkFWUEl4djdwMl9POWlKRU1EVlQ0NDl6WU5FdWxQQzNkTm5DOHB4UGdsRkZENUstaDdFTWZldURGcnNkMlVYRXljTUsyQl9vcXZfUF94WDZhZEdpTl9Vd2M2WWc4eWJrYlpnNExGRVJBWjdiVEl2SGFHakVwT1JtUWZtUXQ0Y1MyMXVSNG5vMWhUaw?oc=5" target="_blank">Impact of Gastric Acid Suppression on Clostridioides difficile Infection: A Systematic Review</a>  <font color="#6f6f6f">Cureus</font>

Atypical C difficile Tied to Treatment Delays, Deaths
Medscapegeneral

Atypical C difficile Tied to Treatment Delays, Deaths

<a href="https://news.google.com/rss/articles/CBMipwFBVV95cUxPdk94Q0tuR2ZfOXFDUUFNdWpaY3lyZzVUbEZmU21GaVV2aXRxOTBoZC1DU2NvNWUzazJLRDVOR3ZFd2JjWVZ1SXNKSm10aWhWLVZXV2xGeW9DUGtFbDc5WlFpU3pZTnRaNWZBM19EaGYwbExLOGNYbkR2TC1FdTBWaGpiT3pObVg0c3drUzE0dXFoOVp4RzBuVXdnY3J4U21rT2M2Zk5LVQ?oc=5" target="_blank">Atypical C difficile Tied to Treatment Delays, Deaths</a>  <font color="#6f6f6f">Medscape</font>

Auxotrophy from bioenergetic demand: the case of proline addiction in Clostridioides difficile
ASM Journalsgeneral

Auxotrophy from bioenergetic demand: the case of proline addiction in Clostridioides difficile

<a href="https://news.google.com/rss/articles/CBMiaEFVX3lxTE54R2ctRllGU3UtTnZLN0V5cDhvQldVWnduaGJEVXFSWUNHenNEbEprRmphdmdEYzFKZXFqR3MtSnlVUWdKRnhIT09MYm1wZV91aERqZGdQT1lVMEU5T1Nua2MyLW5QZjRU?oc=5" target="_blank">Auxotrophy from bioenergetic demand: the case of proline addiction in Clostridioides difficile</a>  <font color="#6f6f6f">ASM Journals</font>

Case Commentary: Emergence of clinically relevant fidaxomicin-resistant Clostridioides difficile strains
ASM Journalstech

Case Commentary: Emergence of clinically relevant fidaxomicin-resistant Clostridioides difficile strains

<a href="https://news.google.com/rss/articles/CBMiZEFVX3lxTE4yVVA0TWZVUUVNU0lBYmhGcDVETlFacjV4bzAzLWwzRUhYVEd2dFcwZEIyODV4Yld6NkNmZHp4Z2J2czBqLVRvUzJTWGEyRmZFa2dBTWgtSEJ4MjFrM0ZQQ3FPdVo?oc=5" target="_blank">Case Commentary: Emergence of clinically relevant fidaxomicin-resistant Clostridioides difficile strains</a>  <font color="#6f6f6f">ASM Journals</font>

Outcome observability in evidence on proton pump inhibitor-associated clostridioides difficile outcomes: a result-specific methodological audit
Frontiersgeneral

Outcome observability in evidence on proton pump inhibitor-associated clostridioides difficile outcomes: a result-specific methodological audit

<a href="https://news.google.com/rss/articles/CBMijgFBVV95cUxQaDdVOS1kOXY0dm5xQjhINWd2S3kxNkxmbHI3bGdfU0lSdzRfNmJKYl9SaHBvVUFlUEVzR2VqelhJbUZ1U2hoYUl0elVSQUhmbHZ4YjNTQzZ5ZnFVTXo0MTVMQ0ctaFdldkFGU0hBMGRTOEpJZDdNTW14TUtmUkZlTFlpRzNRVHZzOEtqanBR?oc=5" target="_blank">Outcome observability in evidence on proton pump inhibitor-associated clostridioides difficile outcomes: a result-specific methodological audit</a>  <font color="#6f6f6f">Frontiers</font>

Novel vaccine protects against C. diff disease and recurrence
Vanderbilt Health Newstech

Novel vaccine protects against C. diff disease and recurrence

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxQb2I2SmFPQmctaV9BQm1pRklFa2ZTbS0xUHBsQWZlMEtNeGxlWUNicGdaSW5GQ2VuV1gwcF9pQ1FVM3EzU2pLU0JyS3RaaS1uX0VfMENhaDhWNl8ybHR2VHJmRnZ2cnVtaG9vYTNlSERNYTU3VElQNkpDTDl1S0lJNHdNb19BaDFRWEthUHZtaGtxemFKaGFIUUpB?oc=5" target="_blank">Novel vaccine protects against C. diff disease and recurrence</a>  <font color="#6f6f6f">Vanderbilt Health News</font>

Clostridioides difficile infection in pediatric inflammatory bowel disease: current understanding and clinical challenges
Frontiersworld

Clostridioides difficile infection in pediatric inflammatory bowel disease: current understanding and clinical challenges

<a href="https://news.google.com/rss/articles/CBMikAFBVV95cUxOM05qdG9SOUVlUmV5b1pSN1Fpb1lvN3RiWEZEWlJhRWpyd2htZTZLdVVtTDY2RjJHRlFzT2pDRlBqTktmazRTWlp1MjBhcHlHUGJoX0E2QUpFeDl4UkNnUHVvX2NTVko4V3owenJSWXdOV0ZZVzJoMHhPS1lFek8zTTZlZnN0eDRTaWl2Q3AzS0Q?oc=5" target="_blank">Clostridioides difficile infection in pediatric inflammatory bowel disease: current understanding and clinical challenges</a>  <font color="#6f6f6f">Frontiers</font>

"Clostridioides difficile" — Live Google News Trends & Headlines